Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aschenbrenner

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The American Journal of Nursing|October 28, 2006
Over-the-counter access to emergency contraceptionDiane S Aschenbrenner
The American Journal of Nursing|February 23, 2007
The conversion of a prescription drug to OTC StatusDiane S Aschenbrenner
The American Journal of Nursing|May 19, 2021
New Treatment for Relapsed or Refractory Large B-cell lymphomaDiane S Aschenbrenner
The American Journal of Nursing|December 23, 2021
New Drug Treats Cervical CancerDiane S Aschenbrenner
The American Journal of Nursing|February 24, 2021
New Treatment for Hypereosinophilic SyndromeDiane S Aschenbrenner
The American Journal of Nursing|October 21, 2021
New Drug for Mismatch Repair Deficient Endometrial Cancer and Solid TumorsDiane S Aschenbrenner
The American Journal of Nursing|July 21, 2022
OTC Products Promoted for Joint, Bone, and Muscle Conditions May Contain Potentially Dangerous Active Drug IngredientsDiane S Aschenbrenner
The American Journal of Nursing|July 21, 2022
New Second-Line Treatment for B-Cell LymphomaDiane S Aschenbrenner
The American Journal of Nursing|February 24, 2022
New Treatment for Polycythemia VeraDiane S Aschenbrenner
The American Journal of Nursing|April 20, 2023
New Combination Asthma DrugDiane S Aschenbrenner
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The American Journal of Nursing|October 28, 2006
Over-the-counter access to emergency contraceptionDiane S Aschenbrenner
The American Journal of Nursing|February 23, 2007
The conversion of a prescription drug to OTC StatusDiane S Aschenbrenner
The American Journal of Nursing|May 19, 2021
New Treatment for Relapsed or Refractory Large B-cell lymphomaDiane S Aschenbrenner
The American Journal of Nursing|December 23, 2021
New Drug Treats Cervical CancerDiane S Aschenbrenner
The American Journal of Nursing|February 24, 2021
New Treatment for Hypereosinophilic SyndromeDiane S Aschenbrenner
The American Journal of Nursing|October 21, 2021
New Drug for Mismatch Repair Deficient Endometrial Cancer and Solid TumorsDiane S Aschenbrenner
The American Journal of Nursing|July 21, 2022
OTC Products Promoted for Joint, Bone, and Muscle Conditions May Contain Potentially Dangerous Active Drug IngredientsDiane S Aschenbrenner
The American Journal of Nursing|July 21, 2022
New Second-Line Treatment for B-Cell LymphomaDiane S Aschenbrenner
The American Journal of Nursing|February 24, 2022
New Treatment for Polycythemia VeraDiane S Aschenbrenner
The American Journal of Nursing|April 20, 2023
New Combination Asthma DrugDiane S Aschenbrenner
Pageof 9